Topics

Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation:

07:20 EDT 2 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 19/09/2006, Revision: 33, Status: Withdrawn

Original Article: Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation:

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: "

Quick Search

Relevant Topics

Cervical Cancer
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...